Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters

被引:70
作者
Panakis, Niki [1 ]
McNair, Helen A. [1 ,3 ]
Christian, Judith A. [1 ]
Mendes, Ruheena [1 ,4 ]
Symonds-Tayler, J. Richard N. [2 ]
Knowles, Clifford [3 ]
Evans, Philip M. [2 ]
Bedford, James [2 ,3 ]
Brada, Michael [1 ,4 ]
机构
[1] Royal Marsden NHS Fdn Trust, Acad Unit Radiotherapy & Oncol, Sutton SM2 5PT, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Joint Dept Phys, Inst Canc Res, Sutton SM2 5PT, Surrey, England
[3] Royal Marsden NHS Fdn Trust, Dept Radiotherapy, Sutton SM2 5PT, Surrey, England
[4] Royal Marsden NHS Fdn Trust, Lung Unit, Sutton SM2 5PT, Surrey, England
关键词
non-small cell lung cancer; active breathing control; treatment margins;
D O I
10.1016/j.radonc.2007.12.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The effectiveness of ABC has been traditionally measured as the reduction in internal margin (IM) within the planning target volume (PTV). Not to overestimate the benefit of ABC, the effect of patient movement during treatment also needs to be taken into account. We determined the IM and set-up error with ABC and the effect on physical lung parameters compared to standard margins used with free breathing. We also assessed interfraction oesophageal movement to determine a planning organ at risk volume (PRV). Materials and methods: Two sequential studies were performed using ABC in NSCLC patients suitable for radical radiotherapy (RT). Twelve out of 14 patients in Study 1 had tumours visible fluoroscopically and had intrafraction tumour movement assessed with and without ABC. Sixteen patients were recruited to Study 2 and had interfraction tumour movement measured using ABC in a moderate deep inspiration breath-hold, of these 7 patients also had interfraction oesophageal movement recorded. Interfraction movement was assessed by CT scan prior to and in the middle and final week of RT. Displacement of the tumour centre of mass and oesophageal borders relative to the first scan provided a measure of movement. Set-up error was measured in 9 patients treated with an in-house lung board adapted for the ABC device. Combining movement and set-up errors determined PTV and PRV margins with ABC. The effect of ABC on mean lung dose (MILD), lung V-20 and V-13 was calculated. Results: ABC in a moderate deep inspiration breath-hold was tolerated in 25 out of 30 patients (83%) in Study 1 and 2. The random contribution of periodic tumour motion was reduced by 90% in the y direction with ABC compared to free-breathing. The magnitude of motion reduction was less in the x and z direction. Combining the systematic and random set-up error in quadrature with the systematic and random intrafraction and interfraction tumour variations with ABC results in a PTV margin of 8.3 mm in the x direction, 12.0 mm in the y direction and 9.8 mm in the z direction. There was a relative mean reduction in MILD, lung V-20 and V-13 of 25%, 21% and 18% with the ABC PTV compared to a free-breathing PTV. Oesophageal movement combined with set-up error resulted in an isotropic PRV of 4.7 mm. Conclusions: The reduction in PTV size with ABC resulted in an 18-25% relative reduction in physical lung parameters. PTV margin reduction has the potential to spare normal lung and allow dose-escalation if coupled with image-guided RT. The oesophageal PRV needs to be considered when irradiating central disease and is of increasing importance with altered RT fractionation and concomitant chemoradiation schedules. Further reductions in PTV and PRV may be possible if patient set-up error was minimised, confirming that attention to patient immobilisation is as important as attempts to control tumour motion. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 36 条
[1]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[2]  
[Anonymous], 1993, 50 ICRU
[3]   Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC):: A meta-analysis of individual data from 1764 patients [J].
Aupérin, A ;
Le Péchoux, C ;
Pignon, JP ;
Koning, C ;
Jeremic, B ;
Clamon, G ;
Einhorn, L ;
Ball, D ;
Trovo, MG ;
Groen, HJM ;
Bonner, JA ;
Le Chevalier, T ;
Arriagada, R .
ANNALS OF ONCOLOGY, 2006, 17 (03) :473-483
[4]   Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration [J].
Barnes, EIA ;
Murray, BR ;
Robinson, DM ;
Underwood, LJ ;
Hanson, J ;
Roa, WHY .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (04) :1091-1098
[5]  
BIR, 2003, GEOM UNC RAD DEF PLA
[6]   Reproducibility of lung tumor position and reduction of lung mass within the planning target volume using active breathing control (ABC) [J].
Cheung, PCF ;
Sixel, KE ;
Tirona, R ;
Ung, YC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05) :1437-1442
[7]   Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer [J].
Erridge, SC ;
Seppenwoolde, Y ;
Muller, SH ;
van Herk, M ;
De Jaeger, K ;
Belderbos, JSA ;
Boersma, LJ ;
Lebesque, JV .
RADIOTHERAPY AND ONCOLOGY, 2003, 66 (01) :75-85
[8]   Effects of averaging over motion and the resulting systematic errors in radiation therapy [J].
Evans, PM ;
Coolens, C ;
Nioutsikou, E .
PHYSICS IN MEDICINE AND BIOLOGY, 2006, 51 (01) :N1-N7
[9]   Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer [J].
Furuse, K ;
Fukuoka, M ;
Kawahara, M ;
Nishikawa, H ;
Takada, Y ;
Kudoh, S ;
Katagami, N ;
Ariyoshi, Y .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2692-2699
[10]   The relationship between local dose and loss of function for irradiated lung [J].
Gopal, R ;
Tucker, SL ;
Komaki, R ;
Liao, ZX ;
Forster, KM ;
Stevens, C ;
Kelly, JF ;
Starkschall, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01) :106-113